Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts

Preeti Kanikarla Marie(The University of Texas MD Anderson Cancer Center), Scott Kopetz(The University of Texas MD Anderson Cancer Center)

Frontiers in Oncology

September 21, 2022

10.3389/fonc.2022.994333

Cited by 19

Related Papers

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

|New England Journal of Medicine|2019|1.4k

Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress

|Cancer Research|2009|159

Efficacy of the combination of MEK and CDK4/6 inhibitors<i>in vitro</i>and<i>in vivo</i>in KRAS mutant colorectal cancer models

|Oncotarget|2016|126